Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…ty or patient preference against surgery. In these individuals, thermal ablation may provide an alternative. This paper describes the protocol f…
…tional study used data from NHANES collected from 2011 to 2023. Depression was diagnosed based on the Patient Health Questionnaire-9 (PHQ-…
…syndrome (GBS), acute disseminated encephalomyelitis (ADEM) and atrial fibrillation (AF) among adults ≥50 years of age in the USA and provide our r…
…ever, the development of neutralising antibodies may compromise adalimumab’s efficacy. This study investigated the incidence and clinical …
….31 discounted QALYs at a lifetime cost of 166,513 units, while bempedoic acid yielded 11.01 discounted QALYs at 389,310 units. Compared with …
…III randomised controlled trials (RCTs) evaluating ranibizumab, brolucizumab, aflibercept, and faricimab in nAMD. Baseline characteristics i…
…nine, carnitine, carglumic acid, L-citrulline, paromomycin, and lactulose. Phenylbutyrate was discontinued due to nasogastric tube obstru…
…arthritis was the most frequent diagnosis (30%).Drugs involved: adalimumab (35%), etanercept (25%), certolizumab (8%), belimumab (6%), ixe…
…tiation.SZC appears to be an effective adjunctive treatment for acute severe hyperkalaemia in patients with renal failure who are already receiving standa…
…4%): 38% biological drugs (BIO), 22% oral antineoplastic drugs (ANEO), and 11% antiretroviral therapy (ART). The breakdown by specia…
…stical significance the data suggest a favourable trend towards Dato-DXd, which could reflect its potential in terms of progression-free…
…iscontinued were J01XX group antibiotics (linezolid, tedizolid, daptomycin) (n=46), with an acceptance rate of 82.6% (n=38).De-escalation …